← All .science files
pmid:38114725
Construction and validation of a novel lysosomal signature for hepatocellular carcinoma prognosis, diagnosis, and therapeutic decision-making.
Jianlin Chen · Gan Gao · Yufang He · Yi Zhang · Haixia Wu · Peng Dai · Qingzhu Zheng · Hengbin Huang · Jiamiao Weng · Yue Zheng · Yi Huang
Scientific reports · 2023 doi:10.1038/s41598-023-49985-3
Paper
complete
Experiment
partial
Data
partial
Analysis
complete
Execution
absent
Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
paper object · 10 fields
authors array · 11 items
claims array · 3 items
[0] object · 6 fields
evidence array · 1 item
[0] object · 3 fields
[1] object · 6 fields
evidence array · 1 item
[0] object · 3 fields
[2] object · 6 fields
target object · 4 fields
evidence array · 1 item
[0] object · 3 fields
gaps array · 0 items
experiment object · 8 fields
steps array · 3 items
[0] object · 13 fields
parameters object · 0 fields
inputs array · 1 item
outputs array · 1 item
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
data object · 3 fields
assets array · 1 item
[0] object · 15 fields
structure object · 4 fields
gaps array · 0 items
analysis object · 4 fields
methods array · 1 item
[0] object · 10 fields
dsl_operations array · 1 item
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
targets array · 1 item
gaps array · 0 items
capability object · 3 fields
requirements array · 1 item
[0] object · 6 fields
assay_families array · 9 items
gaps array · 0 items
readiness object · 8 fields
axes object · 3 fields
method object · 5 fields
required_operations array · 1 item
missing_operations array · 0 items
capability object · 4 fields
data object · 6 fields
accessions array · 0 items
resolved_accessions array · 0 items
statements array · 1 item
can_run object · 3 fields
dsl_operations array · 1 item
assets array · 1 item
steps array · 1 item
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
gaps array · 1 item
review object · 5 fields
machine_critique object · 5 fields
reader object · 5 fields
evidence_check object · 2 fields
usage object · 3 fields
stages array · 1 item
[0] object · 4 fields
gaps array · 3 items
provenance object · 7 fields
entities array · 3 items
activities array · 3 items
[0] object · 4 fields
used array · 3 items
[0] object · 3 fields
[1] object · 3 fields
[2] object · 3 fields
[1] object · 4 fields
agents array · 2 items
lineage object · 4 fields
gaps array · 5 items
assays array · 3 items
[0] object · 11 fields
required_operations array · 0 items
source_hashes object · 1 field
evidence array · 4 items
[1] object · 11 fields
required_operations array · 0 items
source_hashes object · 1 field
evidence array · 4 items
[2] object · 11 fields
required_operations array · 1 item
source_hashes object · 1 field
evidence array · 1 item
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:38114725", "kind": "science-record", "revision": 2, "content_hash": "sha256:c63aa678fbf8bdadde7d57e7fce8e5d3d2b924b2aed49cc72f4bad5bb3a8c480", "created_at": "2026-11-01T19:20:03Z", "updated_at": "2026-11-01T21:32:10Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Construction and validation of a novel lysosomal signature for hepatocellular carcinoma prognosis, diagnosis, and therapeutic decision-making.", "doi": "10.1038/s41598-023-49985-3", "pmid": "38114725", "authors": ["Jianlin Chen", "Gan Gao", "Yufang He", "Yi Zhang", "Haixia Wu", "Peng Dai", "Qingzhu Zheng", "Hengbin Huang", "Jiamiao Weng", "Yue Zheng", "Yi Huang"], "journal": "Scientific reports", "year": 2023, "abstract": "Lysosomes is a well-recognized oncogenic driver and chemoresistance across variable cancer types, and has been associated with tumor invasiveness, metastasis, and poor prognosis. However, the significance of lysosomes in hepatocellular carcinoma (HCC) is not well understood. Lysosomes-related genes (LRGs) were downloaded from Genome Enrichment Analysis (GSEA) databases. Lysosome-related risk score (LRRS), including eight LRGs, was constructed via expression difference analysis (DEGs), univariate and LASSO-penalized Cox regression algorithm based on the TCGA cohort, while the ICGC cohort was obtained for signature validation. Based on GSE149614 Single-cell RNA sequencing data, model gene expression and liver tumor niche were further analyzed. Moreover, the functional enrichments, tumor microenvironment (TME), and genomic variation landscape between LRRSlow/LRRShigh subgroup were systematically investigated. A total of 15 Lysosomes-related differentially expressed genes (DELRGs) in HCC were detected, and then 10 prognosis DELRGs were screened out. Finally, the 8 optimal DELRGs (CLN3, GBA, CTSA, BSG, APLN, SORT1, ANXA2, and LAPTM4B) were selected to construct the LRRS prognosis signature of HCC. LRRS was considered as an independent prognostic factor and was associated with advanced clinicopathological features. LRRS also proved to be a potential marker for HCC diagnosis, especially for early-stage HCC. Then, a nomogram integrating the LRRS and clinical parameters was set up displaying great prognostic predictive performance. Moreover, patients with high LRRS showed higher tumor stemness, higher heterogeneity, and higher genomic alteration status than those in the low LRRS group and enriched in metabolism-related pathways, suggesting its underlying role in the progression and development of liver cancer. Meanwhile, the LRRS can affect the proportion of immunosuppressive cell infiltration, making it a vital immunosuppressive factor in the tumor microenvironment. Additionally, HCC patients with low LRRS were more sensitive to immunotherapy, while patients in the high LRRS group responded better to chemotherapy. Upon single-cell RNA sequencing, CLN3, GBA, and LAPTM4B were found to be specially expressed in hepatocytes, where they promoted cell progression. Finally, RT-qPCR and external datasets confirmed the mRNA expression levels of model genes. This study provided a direct links between LRRS signature and clinical characteristics, tumor microenvironment, and clinical drug-response, highlighting the critical role of lysosome in the development and treatment resistance of liver cancer, providing valuable insights into the prognosis prediction and treatment response of HCC, thereby providing valuable insights into prognostic prediction, early diagnosis, and therapeutic response of HCC.", "claims": [{"id": "claim-method", "statement": "To verify the ability of the LRRS accurately and independently predict the prognosis of HCC patients, univariate and multivariate Cox regression analyses was performed.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:38114725", "locator": "sections[16] \"Stratified analysis, independent prognostic analysis, and diagnostic analysis\" paragraph 3", "quote": "To verify the ability of the LRRS accurately and independently predict the prognosis of HCC patients, univariate and multivariate Cox regression analyses was performed."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The datasets used and/or analyzed during the current study are available from The Cancer Genome Atlas(TCGA, https://portal.gdc.cancer.gov/repository)(search term: TCGA-LIHC), International Cancer Genome Consortium (ICGC) Japanese liver cancer (ICGC-LIRI-JP) cohort (https://dcc.icgc.org/projects/LIRI-JP), HPA (http://www.proteinatlas.org), and from NCBI GEO: GSE144269 and GSE76427, as well as supplementary materials provided in the article.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:38114725", "locator": "sections[33] \"notes\" paragraph 1", "quote": "The datasets used and/or analyzed during the current study are available from The Cancer Genome Atlas(TCGA, https://portal.gdc.cancer.gov/repository)(search term: TCGA-LIHC), International Cancer Genome Consortium (ICGC) Japanese liver cancer (ICGC-LIRI-JP) cohort (https://dcc.icgc.org/projects/LIRI-JP), HPA (http://www.proteinatlas.org), and from NCBI GEO: GSE144269 and GSE76427, as well as supplementary materials provided in the article."}], "state": "complete"}, {"id": "claim-target-result", "statement": "The lysosome-related risk score was an independent prognostic factor for overall survival in HCC.", "kind": "quantitative", "target": {"value": 95.0, "unit": "per cent", "tolerance": null, "source": "According to multivariate cox regression analysis, stage (HR = 1.558, 95% CI = 1.258–1.929) and LRRS (HR = 2.876, 95% CI = 1.923–4.301) was independent factors for OS (Fig. 5A)."}, "evidence": [{"asset": "source:pmid:38114725", "locator": "sections[16] \"Stratified analysis, independent prognostic analysis, and diagnostic analysis\" paragraph 3", "quote": "According to multivariate cox regression analysis, stage (HR = 1.558, 95% CI = 1.258–1.929) and LRRS (HR = 2.876, 95% CI = 1.923–4.301) was independent factors for OS (Fig. 5A)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": "The lysosome-related risk score was an independent prognostic factor for overall survival in HCC.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:38114725"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_absent", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:accession_absent"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:38114725", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1038/s41598-023-49985-3", "sha256": "sha256:a6e75d1d5ab920416ca4253f43768162ded4d90982120ac8c893ada51b56b6be", "bytes": 52687, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1038/s41598-023-49985-3", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC10730614", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}], "gaps": []}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "To verify the ability of the LRRS accurately and independently predict the prognosis of HCC patients, univariate and multivariate Cox regression analyses was performed."}}], "targets": [{"id": "target-published-estimate", "claim_id": "claim-target-result", "operation": "cox_ph", "expected_value": 95.0, "unit": "per cent", "tolerance": null, "state": "complete", "note": "The published estimate as the reader quoted it from the paper. No tolerance is published because the paper states none."}], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["cox_ph"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": [], "resolved_accessions": [], "statements": ["The datasets used and/or analyzed during the current study are available from The Cancer Genome Atlas(TCGA, https://portal.gdc.cancer.gov/repository)(search term: TCGA-LIHC), International Cancer Genome Consortium (ICGC) Japanese liver cancer (ICGC-LIRI-JP) cohort (https://dcc.icgc.org/projects/LIRI-JP), HPA (http://www.proteinatlas.org), and from NCBI GEO: GSE144269 and GSE76427, as well as supplementary materials provided in the article."], "basis": "The paper names no accession to its source data, so the data has to come from the authors."}}, "can_run": {"dsl_operations": ["cox_ph"], "assets": ["source:pmid:38114725"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:None"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T19:03:05Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 14799, "completion_tokens": 2666, "cached_tokens": 256}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:38114725", "type": "paper", "label": "pmid:38114725"}, {"id": "source:pmid:38114725", "type": "manuscript", "label": "PMID 38114725 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:38114725", "type": "paper", "label": "pmid:38114725"}, {"id": "source:pmid:38114725", "type": "manuscript", "label": "PMID 38114725 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-38114725", "type": "extraction", "used": ["source:pmid:38114725"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-None", "type": "accession_resolution", "used": ["data:geo:None"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:38114725", "parent_hash": "sha256:a5efe27bb6d7964c3c8697c788f7fd7fc4ed99eae6a051646f21620830d359fb", "fork_of": null, "generation": 1}, "gaps": ["execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_absent"], "assays": [{"role": "data_generation", "definition_id": "qpcr", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["ere they promoted cell progression. Finally, RT-qPCR and external datasets confirmed the mRNA exp", "they promoted cell progression. Finally, RT-qPCR and external datasets confirmed the mRNA exp", "Methods Cell culture and RT-qPCR Human normal liver cell line (LO2) and human", "DNA was synthesized by MCE RT Master Mix for qPCR II (MCEs, NJ, USA). A GoTaq® qPCR Master Mix"], "order_basis": "paper_text_order:2398", "id": "assay:1"}, {"role": "data_generation", "definition_id": "cell_culture", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["0% FBS (Procell, Wuhan, China). Liver cancer cell lines were cultured in DMEM (Gibco, CA, USA) with 10%FBS. All ce", "gy Co. LTD (Shanghai, China). LO2 cells were cultured in RPMI-1640 (Procell, Wuhan, China) containing", "Wuhan, China). Liver cancer cell lines were cultured in DMEM (Gibco, CA, USA) with 10%FBS. All cells", "(Gibco, CA, USA) with 10%FBS. All cells were cultured in a 5% CO2 incubator humidified at 37 ℃. Total"], "order_basis": "paper_text_order:3045", "id": "assay:2"}, {"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["cox_ph"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["To verify the ability of the LRRS accurately and independently predict the prognosis of HCC patients, univariate and multivariate Cox regression analyses was performed."], "order_basis": "consumes_earlier_output", "id": "assay:3"}]}